Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Digiday+ Research 2026 Creator Marketing Index: A brand guide to social media campaigns
As creator marketing becomes a fixture in many brands’ marketing strategies, creators’ roles are shifting and expanding.
Good ads have a new name, ‘entertainment-first’ and SharkNinja is using it for its holiday campaign
Making ads people want to watch is now a strategy. SharkNinja’s celebrity filled holiday spot shows why.
Here are the questions on advertisers’ minds after the DoorDash-Instacart deal
DoorDash and Instacart are joining forces. Now advertisers want to know what happens to costs, data and measurement.